Fairvalue-Calculator Fairvalue-Calculator
EN DE

Pharmaniaga Berhad, an investment holding company, (7081) Fair Value & Analysis

Healthcare · MY · Market cap 1.7B MYR

Price1.19 MYR
Fair Value0.7100 MYR
Upside-40.3%
Quality94/100
Evidence: High Range 0.4500 MYR – 0.9500 MYR

Fair value as of: Jun 24, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Pharmaniaga Berhad, an investment holding company, (7081) currently trades at 1.19 MYR, while our model-based Fair Value estimate is 0.7100 MYR — implying the stock looks roughly 40.3% overvalued today. We read business quality at 94/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

About the company

Pharmaniaga Berhad, an investment holding company, operates as an integrated healthcare service provider in Malaysia, Indonesia, and internationally. The company operates through Logistics and Distribution, Manufacturing, and Indonesia segments. It is involved in manufacturing, distribution, and marketing of pharmaceutical and medical products, such as generic drugs and over-the-counter medicines; supply and installation of medical and hospital equipment; and research and development of pharmaceutical products. The company also produces and distributes food supplements. In addition, it distributes and trades diagnostic products; and develops OLIN digital platform, an integrated digital platform for ordering, inventory, billing, and sales operations. Further, the company provides logistics services and primary care products for acute diseases and specialty care products for serious and chronic diseases. Pharmaniaga Berhad was founded in 1994 and is based in Shah Alam, Malaysia.

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) -81% Cencora, Inc (C1CO34) -89% Cardinal Health, Inc (CAH) -38% Sigma Healthcare Limited (SIGGF) -67% Sitka Gold Corp (SIG) -88% Shanghai Pharmaceuticals Holding (601607) +112%

Frequently asked questions

Is Pharmaniaga Berhad, an investment holding company, (7081) undervalued?
As of Jun 24, 2026, our model estimates a fair value of 0.7100 MYR versus a price of 1.19 MYR — about −40% (overvalued). Model-based estimate, not financial advice.
What is the fair value of 7081?
Our 21-model fair value for Pharmaniaga Berhad, an investment holding company, is 0.7100 MYR (as of Jun 24, 2026), built from audited fundamentals. The current price is 1.19 MYR.
What is the quality score of 7081?
Pharmaniaga Berhad, an investment holding company, has a Quality Score of 94/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.